ChemPartner PharmaTechLtd (300149) Stock Overview
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
300149 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ChemPartner PharmaTech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.99 |
| 52 Week High | CN¥15.28 |
| 52 Week Low | CN¥5.92 |
| Beta | 1.11 |
| 1 Month Change | -19.57% |
| 3 Month Change | -4.31% |
| 1 Year Change | 69.04% |
| 3 Year Change | 16.16% |
| 5 Year Change | -27.40% |
| Change since IPO | 48.40% |
Recent News & Updates
Recent updates
Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt In A Risky Way?
Dec 10
ChemPartner PharmaTech Co.,Ltd.'s (SZSE:300149) Price Is Right But Growth Is Lacking After Shares Rocket 51%
Sep 30Improved Revenues Required Before ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Stock's 29% Jump Looks Justified
Aug 04Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
Mar 08Shareholder Returns
| 300149 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.5% | -0.9% | 1.2% |
| 1Y | 69.0% | 1.2% | 35.8% |
Return vs Industry: 300149 exceeded the CN Biotechs industry which returned 1.2% over the past year.
Return vs Market: 300149 exceeded the CN Market which returned 35.8% over the past year.
Price Volatility
| 300149 volatility | |
|---|---|
| 300149 Average Weekly Movement | 8.4% |
| Biotechs Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in CN Market | 9.8% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300149's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300149's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,814 | Swee Lian Woo | www.cppt.com.cn |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary
| 300149 fundamental statistics | |
|---|---|
| Market cap | CN¥4.97b |
| Earnings (TTM) | CN¥13.41m |
| Revenue (TTM) | CN¥1.13b |
Is 300149 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300149 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.13b |
| Cost of Revenue | CN¥810.03m |
| Gross Profit | CN¥324.69m |
| Other Expenses | CN¥311.28m |
| Earnings | CN¥13.41m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.027 |
| Gross Margin | 28.61% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 12.6% |
How did 300149 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/01 14:03 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ChemPartner PharmaTech Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CMB International Securities Limited |
| Xiao Bao Liu | Everbright Securities Co. Ltd. |
| Yun ZHANG | Huatai Research |